MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 214 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,577,470 | -66.9% | 157,747 | -58.8% | 0.00% | -100.0% |
| Q2 2023 | $4,764,854 | -3.8% | 383,335 | +8.4% | 0.00% | 0.0% |
| Q1 2023 | $4,954,791 | -11.6% | 353,661 | -9.7% | 0.00% | -50.0% |
| Q4 2022 | $5,605,313 | -85.5% | 391,706 | -74.1% | 0.00% | -83.3% |
| Q3 2022 | $38,643,000 | -7.8% | 1,513,641 | +2.6% | 0.01% | -7.7% |
| Q2 2022 | $41,894,000 | -3.3% | 1,474,620 | +20.1% | 0.01% | +18.2% |
| Q1 2022 | $43,304,000 | -22.9% | 1,227,783 | -8.4% | 0.01% | -21.4% |
| Q4 2021 | $56,172,000 | -63.6% | 1,340,634 | -57.4% | 0.01% | -64.1% |
| Q3 2021 | $154,304,000 | -11.7% | 3,143,904 | -24.9% | 0.04% | -9.3% |
| Q2 2021 | $174,695,000 | +21.7% | 4,186,328 | +3.9% | 0.04% | +13.2% |
| Q1 2021 | $143,548,000 | +29.5% | 4,027,738 | +1.9% | 0.04% | +18.8% |
| Q4 2020 | $110,838,000 | – | 3,951,436 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $216,810,330 | 13.15% |
| 12 West Capital Management LP | 6,463,111 | $64,631,110 | 5.85% |
| Alpine Peaks Capital, LP | 359,300 | $3,593,000 | 2.50% |
| Connacht Asset Management LP | 24,155 | $241,550 | 1.43% |
| QVIDTVM Management LLC | 163,230 | $1,632,300 | 1.27% |
| BRAIDWELL LP | 3,974,857 | $39,748,570 | 1.26% |
| Mesirow Institutional Investment Management, Inc. | 926,277 | $9,262,770 | 0.94% |
| Granite Investment Partners, LLC | 1,488,359 | $14,883,590 | 0.62% |
| CARLSON CAPITAL L P | 635,000 | $6,350,000 | 0.50% |
| Pier Capital, LLC | 290,563 | $2,905,630 | 0.47% |